img

Global Erectile Dysfunction Oral Medications Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Erectile Dysfunction Oral Medications Market Research Report 2024

Sildenafil (Viagra), vardenafil (Levitra, Staxyn), tadalafil (Cialis) and avanafil (Stendra) are oral medications that reverse erectile dysfunction by enhancing the effects of nitric oxide, a natural chemical your body produces that relaxes muscles in the penis.
According to Mr Accuracy reports’s new survey, global Erectile Dysfunction Oral Medications market is projected to reach US$ 166.9 million in 2029, increasing from US$ 131 million in 2022, with the CAGR of 3.6% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Erectile Dysfunction Oral Medications market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Erectile Dysfunction Oral Medications market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Eli Lilly
Pfizer
Bayer
S.K. Chemicals
Teva Pharma
Dong-A ST
Petros Pharmaceuticals
Seoul Pharma
BaiYunShan General Factory
Yabang Pharmacy
Segment by Type
Sildenafil
Tadalafil
Others

Segment by Application


Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Erectile Dysfunction Oral Medications report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Erectile Dysfunction Oral Medications Market Overview
1.1 Product Overview and Scope of Erectile Dysfunction Oral Medications
1.2 Erectile Dysfunction Oral Medications Segment by Type
1.2.1 Global Erectile Dysfunction Oral Medications Market Value Comparison by Type (2024-2034)
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Others
1.3 Erectile Dysfunction Oral Medications Segment by Application
1.3.1 Global Erectile Dysfunction Oral Medications Market Value by Application: (2024-2034)
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Retail Pharmacies
1.3.5 E-Commerce
1.4 Global Erectile Dysfunction Oral Medications Market Size Estimates and Forecasts
1.4.1 Global Erectile Dysfunction Oral Medications Revenue 2018-2029
1.4.2 Global Erectile Dysfunction Oral Medications Sales 2018-2029
1.4.3 Global Erectile Dysfunction Oral Medications Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Erectile Dysfunction Oral Medications Market Competition by Manufacturers
2.1 Global Erectile Dysfunction Oral Medications Sales Market Share by Manufacturers (2018-2024)
2.2 Global Erectile Dysfunction Oral Medications Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Erectile Dysfunction Oral Medications Average Price by Manufacturers (2018-2024)
2.4 Global Erectile Dysfunction Oral Medications Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Erectile Dysfunction Oral Medications, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Erectile Dysfunction Oral Medications, Product Type & Application
2.7 Erectile Dysfunction Oral Medications Market Competitive Situation and Trends
2.7.1 Erectile Dysfunction Oral Medications Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Erectile Dysfunction Oral Medications Players Market Share by Revenue
2.7.3 Global Erectile Dysfunction Oral Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Erectile Dysfunction Oral Medications Retrospective Market Scenario by Region
3.1 Global Erectile Dysfunction Oral Medications Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Erectile Dysfunction Oral Medications Global Erectile Dysfunction Oral Medications Sales by Region: 2018-2029
3.2.1 Global Erectile Dysfunction Oral Medications Sales by Region: 2018-2024
3.2.2 Global Erectile Dysfunction Oral Medications Sales by Region: 2024-2029
3.3 Global Erectile Dysfunction Oral Medications Global Erectile Dysfunction Oral Medications Revenue by Region: 2018-2029
3.3.1 Global Erectile Dysfunction Oral Medications Revenue by Region: 2018-2024
3.3.2 Global Erectile Dysfunction Oral Medications Revenue by Region: 2024-2029
3.4 North America Erectile Dysfunction Oral Medications Market Facts & Figures by Country
3.4.1 North America Erectile Dysfunction Oral Medications Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Erectile Dysfunction Oral Medications Sales by Country (2018-2029)
3.4.3 North America Erectile Dysfunction Oral Medications Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Erectile Dysfunction Oral Medications Market Facts & Figures by Country
3.5.1 Europe Erectile Dysfunction Oral Medications Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Erectile Dysfunction Oral Medications Sales by Country (2018-2029)
3.5.3 Europe Erectile Dysfunction Oral Medications Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Erectile Dysfunction Oral Medications Market Facts & Figures by Country
3.6.1 Asia Pacific Erectile Dysfunction Oral Medications Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Erectile Dysfunction Oral Medications Sales by Country (2018-2029)
3.6.3 Asia Pacific Erectile Dysfunction Oral Medications Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Erectile Dysfunction Oral Medications Market Facts & Figures by Country
3.7.1 Latin America Erectile Dysfunction Oral Medications Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Erectile Dysfunction Oral Medications Sales by Country (2018-2029)
3.7.3 Latin America Erectile Dysfunction Oral Medications Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Erectile Dysfunction Oral Medications Market Facts & Figures by Country
3.8.1 Middle East and Africa Erectile Dysfunction Oral Medications Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Erectile Dysfunction Oral Medications Sales by Country (2018-2029)
3.8.3 Middle East and Africa Erectile Dysfunction Oral Medications Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Erectile Dysfunction Oral Medications Sales by Type (2018-2029)
4.1.1 Global Erectile Dysfunction Oral Medications Sales by Type (2018-2024)
4.1.2 Global Erectile Dysfunction Oral Medications Sales by Type (2024-2029)
4.1.3 Global Erectile Dysfunction Oral Medications Sales Market Share by Type (2018-2029)
4.2 Global Erectile Dysfunction Oral Medications Revenue by Type (2018-2029)
4.2.1 Global Erectile Dysfunction Oral Medications Revenue by Type (2018-2024)
4.2.2 Global Erectile Dysfunction Oral Medications Revenue by Type (2024-2029)
4.2.3 Global Erectile Dysfunction Oral Medications Revenue Market Share by Type (2018-2029)
4.3 Global Erectile Dysfunction Oral Medications Price by Type (2018-2029)
5 Segment by Application
5.1 Global Erectile Dysfunction Oral Medications Sales by Application (2018-2029)
5.1.1 Global Erectile Dysfunction Oral Medications Sales by Application (2018-2024)
5.1.2 Global Erectile Dysfunction Oral Medications Sales by Application (2024-2029)
5.1.3 Global Erectile Dysfunction Oral Medications Sales Market Share by Application (2018-2029)
5.2 Global Erectile Dysfunction Oral Medications Revenue by Application (2018-2029)
5.2.1 Global Erectile Dysfunction Oral Medications Revenue by Application (2018-2024)
5.2.2 Global Erectile Dysfunction Oral Medications Revenue by Application (2024-2029)
5.2.3 Global Erectile Dysfunction Oral Medications Revenue Market Share by Application (2018-2029)
5.3 Global Erectile Dysfunction Oral Medications Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Corporation Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Eli Lilly Erectile Dysfunction Oral Medications Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Pfizer Erectile Dysfunction Oral Medications Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Bayer Erectile Dysfunction Oral Medications Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 S.K. Chemicals
6.4.1 S.K. Chemicals Corporation Information
6.4.2 S.K. Chemicals Description and Business Overview
6.4.3 S.K. Chemicals Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2018-2024)
6.4.4 S.K. Chemicals Erectile Dysfunction Oral Medications Product Portfolio
6.4.5 S.K. Chemicals Recent Developments/Updates
6.5 Teva Pharma
6.5.1 Teva Pharma Corporation Information
6.5.2 Teva Pharma Description and Business Overview
6.5.3 Teva Pharma Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Teva Pharma Erectile Dysfunction Oral Medications Product Portfolio
6.5.5 Teva Pharma Recent Developments/Updates
6.6 Dong-A ST
6.6.1 Dong-A ST Corporation Information
6.6.2 Dong-A ST Description and Business Overview
6.6.3 Dong-A ST Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Dong-A ST Erectile Dysfunction Oral Medications Product Portfolio
6.6.5 Dong-A ST Recent Developments/Updates
6.7 Petros Pharmaceuticals
6.6.1 Petros Pharmaceuticals Corporation Information
6.6.2 Petros Pharmaceuticals Description and Business Overview
6.6.3 Petros Pharmaceuticals Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Petros Pharmaceuticals Erectile Dysfunction Oral Medications Product Portfolio
6.7.5 Petros Pharmaceuticals Recent Developments/Updates
6.8 Seoul Pharma
6.8.1 Seoul Pharma Corporation Information
6.8.2 Seoul Pharma Description and Business Overview
6.8.3 Seoul Pharma Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Seoul Pharma Erectile Dysfunction Oral Medications Product Portfolio
6.8.5 Seoul Pharma Recent Developments/Updates
6.9 BaiYunShan General Factory
6.9.1 BaiYunShan General Factory Corporation Information
6.9.2 BaiYunShan General Factory Description and Business Overview
6.9.3 BaiYunShan General Factory Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2018-2024)
6.9.4 BaiYunShan General Factory Erectile Dysfunction Oral Medications Product Portfolio
6.9.5 BaiYunShan General Factory Recent Developments/Updates
6.10 Yabang Pharmacy
6.10.1 Yabang Pharmacy Corporation Information
6.10.2 Yabang Pharmacy Description and Business Overview
6.10.3 Yabang Pharmacy Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Yabang Pharmacy Erectile Dysfunction Oral Medications Product Portfolio
6.10.5 Yabang Pharmacy Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Erectile Dysfunction Oral Medications Industry Chain Analysis
7.2 Erectile Dysfunction Oral Medications Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Erectile Dysfunction Oral Medications Production Mode & Process
7.4 Erectile Dysfunction Oral Medications Sales and Marketing
7.4.1 Erectile Dysfunction Oral Medications Sales Channels
7.4.2 Erectile Dysfunction Oral Medications Distributors
7.5 Erectile Dysfunction Oral Medications Customers
8 Erectile Dysfunction Oral Medications Market Dynamics
8.1 Erectile Dysfunction Oral Medications Industry Trends
8.2 Erectile Dysfunction Oral Medications Market Drivers
8.3 Erectile Dysfunction Oral Medications Market Challenges
8.4 Erectile Dysfunction Oral Medications Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Erectile Dysfunction Oral Medications Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Erectile Dysfunction Oral Medications Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Erectile Dysfunction Oral Medications Market Competitive Situation by Manufacturers in 2022
Table 4. Global Erectile Dysfunction Oral Medications Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Erectile Dysfunction Oral Medications Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Erectile Dysfunction Oral Medications Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Erectile Dysfunction Oral Medications Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Erectile Dysfunction Oral Medications Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Erectile Dysfunction Oral Medications, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Erectile Dysfunction Oral Medications, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Erectile Dysfunction Oral Medications, Product Type & Application
Table 12. Global Key Manufacturers of Erectile Dysfunction Oral Medications, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Erectile Dysfunction Oral Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erectile Dysfunction Oral Medications as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Erectile Dysfunction Oral Medications Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Erectile Dysfunction Oral Medications Sales by Region (2018-2024) & (K Units)
Table 18. Global Erectile Dysfunction Oral Medications Sales Market Share by Region (2018-2024)
Table 19. Global Erectile Dysfunction Oral Medications Sales by Region (2024-2029) & (K Units)
Table 20. Global Erectile Dysfunction Oral Medications Sales Market Share by Region (2024-2029)
Table 21. Global Erectile Dysfunction Oral Medications Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Erectile Dysfunction Oral Medications Revenue Market Share by Region (2018-2024)
Table 23. Global Erectile Dysfunction Oral Medications Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Erectile Dysfunction Oral Medications Revenue Market Share by Region (2024-2029)
Table 25. North America Erectile Dysfunction Oral Medications Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Erectile Dysfunction Oral Medications Sales by Country (2018-2024) & (K Units)
Table 27. North America Erectile Dysfunction Oral Medications Sales by Country (2024-2029) & (K Units)
Table 28. North America Erectile Dysfunction Oral Medications Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Erectile Dysfunction Oral Medications Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Erectile Dysfunction Oral Medications Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Erectile Dysfunction Oral Medications Sales by Country (2018-2024) & (K Units)
Table 32. Europe Erectile Dysfunction Oral Medications Sales by Country (2024-2029) & (K Units)
Table 33. Europe Erectile Dysfunction Oral Medications Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Erectile Dysfunction Oral Medications Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Erectile Dysfunction Oral Medications Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Erectile Dysfunction Oral Medications Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Erectile Dysfunction Oral Medications Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Erectile Dysfunction Oral Medications Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Erectile Dysfunction Oral Medications Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Erectile Dysfunction Oral Medications Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Erectile Dysfunction Oral Medications Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Erectile Dysfunction Oral Medications Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Erectile Dysfunction Oral Medications Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Erectile Dysfunction Oral Medications Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Erectile Dysfunction Oral Medications Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Erectile Dysfunction Oral Medications Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Erectile Dysfunction Oral Medications Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Erectile Dysfunction Oral Medications Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Erectile Dysfunction Oral Medications Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Erectile Dysfunction Oral Medications Sales (K Units) by Type (2018-2024)
Table 51. Global Erectile Dysfunction Oral Medications Sales (K Units) by Type (2024-2029)
Table 52. Global Erectile Dysfunction Oral Medications Sales Market Share by Type (2018-2024)
Table 53. Global Erectile Dysfunction Oral Medications Sales Market Share by Type (2024-2029)
Table 54. Global Erectile Dysfunction Oral Medications Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Erectile Dysfunction Oral Medications Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Erectile Dysfunction Oral Medications Revenue Market Share by Type (2018-2024)
Table 57. Global Erectile Dysfunction Oral Medications Revenue Market Share by Type (2024-2029)
Table 58. Global Erectile Dysfunction Oral Medications Price (US$/Unit) by Type (2018-2024)
Table 59. Global Erectile Dysfunction Oral Medications Price (US$/Unit) by Type (2024-2029)
Table 60. Global Erectile Dysfunction Oral Medications Sales (K Units) by Application (2018-2024)
Table 61. Global Erectile Dysfunction Oral Medications Sales (K Units) by Application (2024-2029)
Table 62. Global Erectile Dysfunction Oral Medications Sales Market Share by Application (2018-2024)
Table 63. Global Erectile Dysfunction Oral Medications Sales Market Share by Application (2024-2029)
Table 64. Global Erectile Dysfunction Oral Medications Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Erectile Dysfunction Oral Medications Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Erectile Dysfunction Oral Medications Revenue Market Share by Application (2018-2024)
Table 67. Global Erectile Dysfunction Oral Medications Revenue Market Share by Application (2024-2029)
Table 68. Global Erectile Dysfunction Oral Medications Price (US$/Unit) by Application (2018-2024)
Table 69. Global Erectile Dysfunction Oral Medications Price (US$/Unit) by Application (2024-2029)
Table 70. Eli Lilly Corporation Information
Table 71. Eli Lilly Description and Business Overview
Table 72. Eli Lilly Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Eli Lilly Erectile Dysfunction Oral Medications Product
Table 74. Eli Lilly Recent Developments/Updates
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Pfizer Erectile Dysfunction Oral Medications Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Bayer Corporation Information
Table 81. Bayer Description and Business Overview
Table 82. Bayer Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Bayer Erectile Dysfunction Oral Medications Product
Table 84. Bayer Recent Developments/Updates
Table 85. S.K. Chemicals Corporation Information
Table 86. S.K. Chemicals Description and Business Overview
Table 87. S.K. Chemicals Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. S.K. Chemicals Erectile Dysfunction Oral Medications Product
Table 89. S.K. Chemicals Recent Developments/Updates
Table 90. Teva Pharma Corporation Information
Table 91. Teva Pharma Description and Business Overview
Table 92. Teva Pharma Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Teva Pharma Erectile Dysfunction Oral Medications Product
Table 94. Teva Pharma Recent Developments/Updates
Table 95. Dong-A ST Corporation Information
Table 96. Dong-A ST Description and Business Overview
Table 97. Dong-A ST Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Dong-A ST Erectile Dysfunction Oral Medications Product
Table 99. Dong-A ST Recent Developments/Updates
Table 100. Petros Pharmaceuticals Corporation Information
Table 101. Petros Pharmaceuticals Description and Business Overview
Table 102. Petros Pharmaceuticals Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Petros Pharmaceuticals Erectile Dysfunction Oral Medications Product
Table 104. Petros Pharmaceuticals Recent Developments/Updates
Table 105. Seoul Pharma Corporation Information
Table 106. Seoul Pharma Description and Business Overview
Table 107. Seoul Pharma Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Seoul Pharma Erectile Dysfunction Oral Medications Product
Table 109. Seoul Pharma Recent Developments/Updates
Table 110. BaiYunShan General Factory Corporation Information
Table 111. BaiYunShan General Factory Description and Business Overview
Table 112. BaiYunShan General Factory Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. BaiYunShan General Factory Erectile Dysfunction Oral Medications Product
Table 114. BaiYunShan General Factory Recent Developments/Updates
Table 115. Yabang Pharmacy Corporation Information
Table 116. Yabang Pharmacy Description and Business Overview
Table 117. Yabang Pharmacy Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Yabang Pharmacy Erectile Dysfunction Oral Medications Product
Table 119. Yabang Pharmacy Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Erectile Dysfunction Oral Medications Distributors List
Table 123. Erectile Dysfunction Oral Medications Customers List
Table 124. Erectile Dysfunction Oral Medications Market Trends
Table 125. Erectile Dysfunction Oral Medications Market Drivers
Table 126. Erectile Dysfunction Oral Medications Market Challenges
Table 127. Erectile Dysfunction Oral Medications Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Erectile Dysfunction Oral Medications
Figure 2. Global Erectile Dysfunction Oral Medications Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Erectile Dysfunction Oral Medications Market Share by Type in 2022 & 2029
Figure 4. Sildenafil Product Picture
Figure 5. Tadalafil Product Picture
Figure 6. Others Product Picture
Figure 7. Global Erectile Dysfunction Oral Medications Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Erectile Dysfunction Oral Medications Market Share by Application in 2022 & 2029
Figure 9. Hospital Pharmacies
Figure 10. Private Clinics
Figure 11. Retail Pharmacies
Figure 12. E-Commerce
Figure 13. Global Erectile Dysfunction Oral Medications Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Erectile Dysfunction Oral Medications Market Size (2018-2029) & (US$ Million)
Figure 15. Global Erectile Dysfunction Oral Medications Sales (2018-2029) & (K Units)
Figure 16. Global Erectile Dysfunction Oral Medications Average Price (US$/Unit) & (2018-2029)
Figure 17. Erectile Dysfunction Oral Medications Report Years Considered
Figure 18. Erectile Dysfunction Oral Medications Sales Share by Manufacturers in 2022
Figure 19. Global Erectile Dysfunction Oral Medications Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Erectile Dysfunction Oral Medications Players: Market Share by Revenue in 2022
Figure 21. Erectile Dysfunction Oral Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Erectile Dysfunction Oral Medications Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Erectile Dysfunction Oral Medications Sales Market Share by Country (2018-2029)
Figure 24. North America Erectile Dysfunction Oral Medications Revenue Market Share by Country (2018-2029)
Figure 25. United States Erectile Dysfunction Oral Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Erectile Dysfunction Oral Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Erectile Dysfunction Oral Medications Sales Market Share by Country (2018-2029)
Figure 28. Europe Erectile Dysfunction Oral Medications Revenue Market Share by Country (2018-2029)
Figure 29. Germany Erectile Dysfunction Oral Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Erectile Dysfunction Oral Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Erectile Dysfunction Oral Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Erectile Dysfunction Oral Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Erectile Dysfunction Oral Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Erectile Dysfunction Oral Medications Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Erectile Dysfunction Oral Medications Revenue Market Share by Region (2018-2029)
Figure 36. China Erectile Dysfunction Oral Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Erectile Dysfunction Oral Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Erectile Dysfunction Oral Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Erectile Dysfunction Oral Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Erectile Dysfunction Oral Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan Erectile Dysfunction Oral Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Southeast Asia Erectile Dysfunction Oral Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Erectile Dysfunction Oral Medications Sales Market Share by Country (2018-2029)
Figure 44. Latin America Erectile Dysfunction Oral Medications Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Erectile Dysfunction Oral Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Erectile Dysfunction Oral Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Erectile Dysfunction Oral Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Erectile Dysfunction Oral Medications Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Erectile Dysfunction Oral Medications Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Erectile Dysfunction Oral Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Erectile Dysfunction Oral Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Erectile Dysfunction Oral Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Erectile Dysfunction Oral Medications by Type (2018-2029)
Figure 54. Global Revenue Market Share of Erectile Dysfunction Oral Medications by Type (2018-2029)
Figure 55. Global Erectile Dysfunction Oral Medications Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Erectile Dysfunction Oral Medications by Application (2018-2029)
Figure 57. Global Revenue Market Share of Erectile Dysfunction Oral Medications by Application (2018-2029)
Figure 58. Global Erectile Dysfunction Oral Medications Price (US$/Unit) by Application (2018-2029)
Figure 59. Erectile Dysfunction Oral Medications Value Chain
Figure 60. Erectile Dysfunction Oral Medications Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries